Advances in the Study of the Ubiquitin-Editing Enzyme A20
Open Access
- 3 May 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 13, 845262
Abstract
Ubiquitin modification is a common post-translational protein modification and an important mechanism whereby the body regulates protein levels and functions. As a common enzyme associated with ubiquitin modification, the ubiquitin-editing enzyme A20 may be closely associated with the development of numerous pathological processes through its different structural domains. The aim of this paper is to provide an overview of the following: advances in ubiquitination research, the structure and function of A20, and the relationships between A20 and immune inflammatory response, apoptosis, necroptosis, pyroptosis, and autophagy.Keywords
This publication has 93 references indexed in Scilit:
- Regulation of NF‐κB by deubiquitinasesImmunological Reviews, 2012
- Regulation of NF-κB signaling by the A20 deubiquitinaseCellular & Molecular Immunology, 2012
- Functional complementation between FADD and RIP1 in embryos and lymphocytesNature, 2011
- RIP3 mediates the embryonic lethality of caspase-8-deficient miceNature, 2011
- The Ubiquitin Modifying Enzyme A20 Restricts B Cell Survival and Prevents AutoimmunityImmunity, 2010
- Inhibition of NF-κB Signaling by A20 Through Disruption of Ubiquitin Enzyme ComplexesScience, 2010
- The emerging complexity of protein ubiquitinationBiochemical Society Transactions, 2009
- Cullin3-Based Polyubiquitination and p62-Dependent Aggregation of Caspase-8 Mediate Extrinsic Apoptosis SignalingCell, 2009
- The Ubiquitin-Editing Enzyme A20 Restricts Nucleotide-Binding Oligomerization Domain Containing 2-Triggered SignalsImmunity, 2008
- De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signallingNature, 2004